X线诊断要点丨软骨发育不全、脊柱骨骺发育不良、半肢骨骺发育异常

2021-10-28 熊猫放射 熊猫放射

太详细了,值得收藏学习!

软骨发育不全的诊断要点是什么?

本病为常染色体显性遗传。出生后即见异常,典型短肢型侏儒、颅大面小、“三叉戟”样手,智力正常,四肢变短,尤以近端(股、肱骨)为著。
X线表现:

①长管骨粗短弯曲,干骺端增宽呈“杯口”或“V”型,骨骺被其包埋,以膝部表现为显著。骺板光滑或轻度不整(是与佝偻病、粘多糖病Ⅳ型以及干骺发育障碍鉴别的要点),并有散在点状致密影,手足短管骨亦粗短。

②腰椎椎体后缘轻度凹陷,前部稍呈楔形,正位片上椎弓根间距自上而下逐渐变小(与正常相反)以及坐骨大切迹“鱼口”状改变,为本病特征性表现。

 

图片

图片

 

 

假性软骨发育不全与软骨发育不全如何鉴别?
图片

图片

 

 

脊柱骨骺发育不良分为哪四型?诊断要点是什么?

本病是一组选择性累及脊柱和管状骨骨骺的软骨发育异常。主要有以下四型:
(1)早发型脊柱骨骺发育不良:为常染色体显性遗传,生后即见异常,为短躯干型侏儒,各年龄组X线表现均有明显异常。主要累及脊柱、骨盆和长管状骨。X线表现为骨化延迟、椎体变扁及椎间隙变窄致躯干显著变短,长骨骨骺小及不规整,以股骨和肱骨为显著。
(2)晚发型脊柱骨骺发育不良:为性链隐性遗传、男性发病,5岁后出现症状,为短躯干侏儒、小骨盆。脊柱和髋有典型改变:普遍性椎体变扁,前后径增加,推间隙狭窄,下胸和腰椎椎体中后部的上下缘驼峰状突起,侧位呈横置的花瓶样,椎弓根间距正常。骨盆狭小,髋臼发育不良,股骨头扁小,可有囊变。四肢大关节发育不良,较早发生退行性变。
(3)晚发型脊柱骨骺发育不良伴进行性关节病:为常染色体隐性遗传,3~8岁发病,为短躯干侏儒,四肢关节肿大但无软组织肿胀。X线特点是普遍性椎体变扁,椎体前后、左右径增大,椎间隙变窄,椎弓根变短。无椎体中后部典型的驼峰状突起。四肢长、短管状骨骨骺和干骺增大并向侧方突出,关节间隙窄。短管状骨及腕、踝关节受累应与大骨节病相鉴别,后者为地方病,脊柱和四肢近侧大关节很少有改变。
(4)假性软骨发育不全:又称为骨骺、干骺端发育异常。本病为脊柱骨骺发育不良的肢体型。患者生后正常,两岁以后发育迟缓,头颅正常,短肢侏儒,骨骺及干骺的表现较为特征。骨骺小,不规整或碎裂,干骺增宽及结构不规整。椎体前缘轻度台阶状改变或变扁呈椭圆形,生长期可达正常高度, 腰椎弓根间距正常。坐骨大切迹小,但较轻。

 

图片

图片
图片

晚发型

 

图片

迟发型脊柱骨骺发育不良伴进行性关节病

 

 

多发性骨骺发育不良的诊断要点是什么?

本病约50%系家族性发病。4岁以后出现关节疼痛和运动障碍,身材较矮小,四肢和躯干基本匀称。病变只侵及骨骺,以儿童时期最显著
X线表现:对称性两侧骨骺发育小而扁,边缘不规则,可呈分节或斑点状, 但无硬化,骨骺闭合时间通常正常。典型表现为胫骨远端骨骺外侧部分发育不良,导致骨骺呈尖端指向外侧的楔形及踝关节倾斜,患部较早发生关节退行性变。
图片
图片

图片

干骺发育不良有何X线特点?分为几型?

本病系一种全身管状骨干骺端的软骨发育异常,可能因骺板不均匀性缺血导致软骨细胞不规则增生所致。其特点是两侧对称性干骺端杯口状增宽、缺损和不规则钙化。本病分三型:

(1)景森 (Jansen) 型:很少见,无家族遗传性,出生时即见异常。病变主要累及长管状骨的干骺端,分布对称,尤以下肢髋、膝、踝部最明显。

(2)施密特(shmid)型:系常染色体显性遗传,多于3~4岁以后出现异常。股骨近端颇具特征:股骨颈粗短,结构不规则,骺板呈垂直位且增宽,髋内翻,头正常。下肢长管状骨可变短和弯曲。

(3)施巴尔(spahr)型:为常染色体隐性遗传,干骺端轻度不规则,但下肢骨常有明显的弯曲畸形。

图片

Schmid型干骺端软骨发育异常

 

图片

女,5岁,身材矮小,头面部发育正常,神清合作,智力正常,轻度髋内翻鸭步态,躯干短小,双膝内翻畸形。图1:双手2~4指骨短而粗(白箭头),双手掌骨干骺端加宽外展呈杯口状陷凹,临时钙化带不整,部分消失,部分致密,厚薄不均。骺骸嵌入陷凹中,并变形和变大(黑长箭示)。腕骨二次骨化中心有3块。尺骨骺板斜陷,临时期钙化带厚薄不均,但以增厚硬化为主。桡骨中心部反致密增厚、骺核陷入其中,内见不规则的钙化斑(黑箭示) 图2:双髋臼缘变浅拉长,边缘不整,临时钙化带明显厚薄密度不均,其内亦可见大小不等不规则钙斑,以髂骨侧为重。股骨颈变短增宽,颈干角:右为145°,左为148°,股骨干骺稍加宽内凹,临时钙化带略不整。大粗隆骺大而不规则。股骨干颈宽而短(图2)。

图片

 

 

半肢骨骺发育异常的诊断要点是什么?

本病又名“Trevor”病、单侧骨骺发育不良、骨骺骨软骨瘤等。系单侧肢体骺软骨偏心性过度生长,形成额外骨块,表面覆盖正常软骨。男性发病约为女性的3倍,2~14岁发病,可有家族史。有学者将其分为3型:①局限型:仅累及一个骨骺;②典型型:单一肢体的多个骨骺受累;③全身型。
X线表现:发生在一侧肢体,累及一个或多个关节,以踝、膝关节最常见。若多个骨骺受累,常分布于同侧、内侧或外侧(内侧多见,是外侧的2~3倍),但亦可一处在内侧,另一处在外侧:病变早期,在同骺、跗或腕骨相连的软组织肿块内可见絮状钙化;与之相邻的二次骨化中心常较对侧出现早,且不规则增大。病变成熟时形成局限性骨性肿块,且部分或整个与邻接的骨骺相融合。常伴关节内翻或外翻畸形。

 

图片

图片

患者,女,14岁。查体:神志清,营养及发育正常,心肺正常。左膝关节、左肘关节及双腕关节畸形,关节周围可触及硬性包块,其中左膝关节内侧肿块约2.5 cm×3.1cm,关节呈外翻畸形。双前臂向背侧弯曲,略短缩。双腕关节背侧可触及大小约2.3 cm×2.5cm大小的肿块,皮肤未见明显异常改变。 

患者,男,38岁。查体:正常面容,双膝呈外翻畸形,关节内侧均可触及硬性包块,大小约2.4 cm×3.0cm;双腕关节外侧呈对称硬性包块,轻度畸形改变,双肘关节未见明显异常。

女儿:左股骨远端及左胫骨近端内侧骨骺增大,关节面清晰,内侧关节面略低;左桡骨近端短缩,近端尺桡关节脱位;左腕关节畸形,尺桡骨远端骨骺增大,桡腕关节面呈“V”形,尺桡骨向背侧弯曲(图1~3);父亲:双股骨远端内侧及双胫骨近端内侧关节面下异常肥大,关节间隙未见明显异常;双桡骨远端外侧肥大,尺桡关节间隙略增宽。双腕关节畸形,桡骨干略向背侧侧成角畸形,以上软组织未见明显异常(图5ab,6ab)。

以上文字内容节选自《放射诊断要点与难点解析》(田军、孟庆学主编)

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1704769, encodeId=3dfb1e04769e2, content=<a href='/topic/show?id=59e63e94572' target=_blank style='color:#2F92EE;'>#发育异常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37945, encryptionId=59e63e94572, topicName=发育异常)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=803330824839, createdName=jjjiang0209, createdTime=Thu May 05 19:27:50 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1298059, encodeId=49141298059da, content=<a href='/topic/show?id=c42d18892ad' target=_blank style='color:#2F92EE;'>#X线#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18892, encryptionId=c42d18892ad, topicName=X线)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c64275, createdName=piaojinhua, createdTime=Sat Oct 30 13:27:50 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1347584, encodeId=030b134e584b2, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Sat Oct 30 13:27:50 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568013, encodeId=5373156801362, content=<a href='/topic/show?id=7a833e94079' target=_blank style='color:#2F92EE;'>#发育不良#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37940, encryptionId=7a833e94079, topicName=发育不良)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30b515313716, createdName=villahu, createdTime=Sat Oct 30 13:27:50 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1592108, encodeId=ce441592108d4, content=<a href='/topic/show?id=a6709164e74' target=_blank style='color:#2F92EE;'>#诊断要点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91647, encryptionId=a6709164e74, topicName=诊断要点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ae18086679, createdName=俅侠, createdTime=Sat Oct 30 13:27:50 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064900, encodeId=d672106490044, content=系统,使用标准12导联心电图信息非侵, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Fri Oct 29 08:57:38 CST 2021, time=2021-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064838, encodeId=b83810648389b, content=积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a2c5479093, createdName=ms4000001350683783, createdTime=Thu Oct 28 23:08:13 CST 2021, time=2021-10-28, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1704769, encodeId=3dfb1e04769e2, content=<a href='/topic/show?id=59e63e94572' target=_blank style='color:#2F92EE;'>#发育异常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37945, encryptionId=59e63e94572, topicName=发育异常)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=803330824839, createdName=jjjiang0209, createdTime=Thu May 05 19:27:50 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1298059, encodeId=49141298059da, content=<a href='/topic/show?id=c42d18892ad' target=_blank style='color:#2F92EE;'>#X线#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18892, encryptionId=c42d18892ad, topicName=X线)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c64275, createdName=piaojinhua, createdTime=Sat Oct 30 13:27:50 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1347584, encodeId=030b134e584b2, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Sat Oct 30 13:27:50 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568013, encodeId=5373156801362, content=<a href='/topic/show?id=7a833e94079' target=_blank style='color:#2F92EE;'>#发育不良#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37940, encryptionId=7a833e94079, topicName=发育不良)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30b515313716, createdName=villahu, createdTime=Sat Oct 30 13:27:50 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1592108, encodeId=ce441592108d4, content=<a href='/topic/show?id=a6709164e74' target=_blank style='color:#2F92EE;'>#诊断要点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91647, encryptionId=a6709164e74, topicName=诊断要点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ae18086679, createdName=俅侠, createdTime=Sat Oct 30 13:27:50 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064900, encodeId=d672106490044, content=系统,使用标准12导联心电图信息非侵, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Fri Oct 29 08:57:38 CST 2021, time=2021-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064838, encodeId=b83810648389b, content=积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a2c5479093, createdName=ms4000001350683783, createdTime=Thu Oct 28 23:08:13 CST 2021, time=2021-10-28, status=1, ipAttribution=)]
    2021-10-30 piaojinhua
  3. [GetPortalCommentsPageByObjectIdResponse(id=1704769, encodeId=3dfb1e04769e2, content=<a href='/topic/show?id=59e63e94572' target=_blank style='color:#2F92EE;'>#发育异常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37945, encryptionId=59e63e94572, topicName=发育异常)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=803330824839, createdName=jjjiang0209, createdTime=Thu May 05 19:27:50 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1298059, encodeId=49141298059da, content=<a href='/topic/show?id=c42d18892ad' target=_blank style='color:#2F92EE;'>#X线#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18892, encryptionId=c42d18892ad, topicName=X线)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c64275, createdName=piaojinhua, createdTime=Sat Oct 30 13:27:50 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1347584, encodeId=030b134e584b2, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Sat Oct 30 13:27:50 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568013, encodeId=5373156801362, content=<a href='/topic/show?id=7a833e94079' target=_blank style='color:#2F92EE;'>#发育不良#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37940, encryptionId=7a833e94079, topicName=发育不良)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30b515313716, createdName=villahu, createdTime=Sat Oct 30 13:27:50 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1592108, encodeId=ce441592108d4, content=<a href='/topic/show?id=a6709164e74' target=_blank style='color:#2F92EE;'>#诊断要点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91647, encryptionId=a6709164e74, topicName=诊断要点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ae18086679, createdName=俅侠, createdTime=Sat Oct 30 13:27:50 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064900, encodeId=d672106490044, content=系统,使用标准12导联心电图信息非侵, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Fri Oct 29 08:57:38 CST 2021, time=2021-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064838, encodeId=b83810648389b, content=积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a2c5479093, createdName=ms4000001350683783, createdTime=Thu Oct 28 23:08:13 CST 2021, time=2021-10-28, status=1, ipAttribution=)]
    2021-10-30 neurowu
  4. [GetPortalCommentsPageByObjectIdResponse(id=1704769, encodeId=3dfb1e04769e2, content=<a href='/topic/show?id=59e63e94572' target=_blank style='color:#2F92EE;'>#发育异常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37945, encryptionId=59e63e94572, topicName=发育异常)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=803330824839, createdName=jjjiang0209, createdTime=Thu May 05 19:27:50 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1298059, encodeId=49141298059da, content=<a href='/topic/show?id=c42d18892ad' target=_blank style='color:#2F92EE;'>#X线#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18892, encryptionId=c42d18892ad, topicName=X线)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c64275, createdName=piaojinhua, createdTime=Sat Oct 30 13:27:50 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1347584, encodeId=030b134e584b2, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Sat Oct 30 13:27:50 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568013, encodeId=5373156801362, content=<a href='/topic/show?id=7a833e94079' target=_blank style='color:#2F92EE;'>#发育不良#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37940, encryptionId=7a833e94079, topicName=发育不良)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30b515313716, createdName=villahu, createdTime=Sat Oct 30 13:27:50 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1592108, encodeId=ce441592108d4, content=<a href='/topic/show?id=a6709164e74' target=_blank style='color:#2F92EE;'>#诊断要点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91647, encryptionId=a6709164e74, topicName=诊断要点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ae18086679, createdName=俅侠, createdTime=Sat Oct 30 13:27:50 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064900, encodeId=d672106490044, content=系统,使用标准12导联心电图信息非侵, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Fri Oct 29 08:57:38 CST 2021, time=2021-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064838, encodeId=b83810648389b, content=积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a2c5479093, createdName=ms4000001350683783, createdTime=Thu Oct 28 23:08:13 CST 2021, time=2021-10-28, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1704769, encodeId=3dfb1e04769e2, content=<a href='/topic/show?id=59e63e94572' target=_blank style='color:#2F92EE;'>#发育异常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37945, encryptionId=59e63e94572, topicName=发育异常)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=803330824839, createdName=jjjiang0209, createdTime=Thu May 05 19:27:50 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1298059, encodeId=49141298059da, content=<a href='/topic/show?id=c42d18892ad' target=_blank style='color:#2F92EE;'>#X线#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18892, encryptionId=c42d18892ad, topicName=X线)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c64275, createdName=piaojinhua, createdTime=Sat Oct 30 13:27:50 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1347584, encodeId=030b134e584b2, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Sat Oct 30 13:27:50 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568013, encodeId=5373156801362, content=<a href='/topic/show?id=7a833e94079' target=_blank style='color:#2F92EE;'>#发育不良#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37940, encryptionId=7a833e94079, topicName=发育不良)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30b515313716, createdName=villahu, createdTime=Sat Oct 30 13:27:50 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1592108, encodeId=ce441592108d4, content=<a href='/topic/show?id=a6709164e74' target=_blank style='color:#2F92EE;'>#诊断要点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91647, encryptionId=a6709164e74, topicName=诊断要点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ae18086679, createdName=俅侠, createdTime=Sat Oct 30 13:27:50 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064900, encodeId=d672106490044, content=系统,使用标准12导联心电图信息非侵, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Fri Oct 29 08:57:38 CST 2021, time=2021-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064838, encodeId=b83810648389b, content=积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a2c5479093, createdName=ms4000001350683783, createdTime=Thu Oct 28 23:08:13 CST 2021, time=2021-10-28, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1704769, encodeId=3dfb1e04769e2, content=<a href='/topic/show?id=59e63e94572' target=_blank style='color:#2F92EE;'>#发育异常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37945, encryptionId=59e63e94572, topicName=发育异常)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=803330824839, createdName=jjjiang0209, createdTime=Thu May 05 19:27:50 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1298059, encodeId=49141298059da, content=<a href='/topic/show?id=c42d18892ad' target=_blank style='color:#2F92EE;'>#X线#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18892, encryptionId=c42d18892ad, topicName=X线)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c64275, createdName=piaojinhua, createdTime=Sat Oct 30 13:27:50 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1347584, encodeId=030b134e584b2, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Sat Oct 30 13:27:50 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568013, encodeId=5373156801362, content=<a href='/topic/show?id=7a833e94079' target=_blank style='color:#2F92EE;'>#发育不良#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37940, encryptionId=7a833e94079, topicName=发育不良)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30b515313716, createdName=villahu, createdTime=Sat Oct 30 13:27:50 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1592108, encodeId=ce441592108d4, content=<a href='/topic/show?id=a6709164e74' target=_blank style='color:#2F92EE;'>#诊断要点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91647, encryptionId=a6709164e74, topicName=诊断要点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ae18086679, createdName=俅侠, createdTime=Sat Oct 30 13:27:50 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064900, encodeId=d672106490044, content=系统,使用标准12导联心电图信息非侵, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Fri Oct 29 08:57:38 CST 2021, time=2021-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064838, encodeId=b83810648389b, content=积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a2c5479093, createdName=ms4000001350683783, createdTime=Thu Oct 28 23:08:13 CST 2021, time=2021-10-28, status=1, ipAttribution=)]
    2021-10-29 查查佳佳

    系统,使用标准12导联心电图信息非侵

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1704769, encodeId=3dfb1e04769e2, content=<a href='/topic/show?id=59e63e94572' target=_blank style='color:#2F92EE;'>#发育异常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37945, encryptionId=59e63e94572, topicName=发育异常)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=803330824839, createdName=jjjiang0209, createdTime=Thu May 05 19:27:50 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1298059, encodeId=49141298059da, content=<a href='/topic/show?id=c42d18892ad' target=_blank style='color:#2F92EE;'>#X线#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18892, encryptionId=c42d18892ad, topicName=X线)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c64275, createdName=piaojinhua, createdTime=Sat Oct 30 13:27:50 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1347584, encodeId=030b134e584b2, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Sat Oct 30 13:27:50 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568013, encodeId=5373156801362, content=<a href='/topic/show?id=7a833e94079' target=_blank style='color:#2F92EE;'>#发育不良#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37940, encryptionId=7a833e94079, topicName=发育不良)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30b515313716, createdName=villahu, createdTime=Sat Oct 30 13:27:50 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1592108, encodeId=ce441592108d4, content=<a href='/topic/show?id=a6709164e74' target=_blank style='color:#2F92EE;'>#诊断要点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91647, encryptionId=a6709164e74, topicName=诊断要点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ae18086679, createdName=俅侠, createdTime=Sat Oct 30 13:27:50 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064900, encodeId=d672106490044, content=系统,使用标准12导联心电图信息非侵, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Fri Oct 29 08:57:38 CST 2021, time=2021-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064838, encodeId=b83810648389b, content=积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a2c5479093, createdName=ms4000001350683783, createdTime=Thu Oct 28 23:08:13 CST 2021, time=2021-10-28, status=1, ipAttribution=)]
    2021-10-28 ms4000001350683783

    积分

    0

相关资讯

FDA授予CNP孤儿药物认定用以治疗软骨发育不全

Ascendis是一家生物制药公司,利用其创新的TransCon™技术解决未满足的医疗需求,Ascendis今天宣布美国食品和药品监督管理局(FDA)已授予C型利钠肽(CNP)孤儿药物认定用于治疗软骨发育不全的儿童。

NEJM:C型利钠肽类似物治疗儿童软骨发育不全

由此可见,在软骨发育不全的儿童中,每日一次皮下注射Vosoritide与副作用相关,其通常看起来是轻微的。治疗导致年度生长速度持续增加长达42个月。

Nature:侏儒症,或有药可医

根据发表在9月17日《自然》(Nature)杂志上的一项研究,他汀类药物(statins)或许可以帮助因FGFR3突变患有侏儒症(又称矮小症)的人骨骼生长。研究人员将源自患者皮肤细胞的诱导干细胞(iPSCs)分化为软骨细胞,利用这些细胞他们在药物筛查的过程中鉴别出了降胆固醇药的促生长特性。这些患者患有最常见的侏儒症形式:软骨发育不全(achondroplasi),以及一种叫做1型致死性发育不全(T

维昇药业TransCon C-型利钠肽II期中国临床试验申请获批

1月7日,维昇药业(VISEN Pharmaceuticals)宣布其向中国国家药品监督管理局(NMPA)递交的注射用TransCon CNP(TransCon C-型利钠肽)用于软骨发育不全(ACH

2019 JSPE临床实践指南:软骨发育不全

2019年1月,日本小儿内分泌学会(JSPE)发布了软骨发育不全管理指南,软骨发育不全(ACH)是一种骨骼发育不全,主要表现为肢体缩短、身材矮小和面部特征性表现。本文主要针对软骨发育不全的临床管理提出指导建议,涉及诊断和治疗。